SCHEMBL21101673

SCHEMBL21101673

c1ccc2c(c1)nc1[nH]c3ncccc3n12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.48
KDM4E B2RXH2 5/20 0.48
HPGD P15428 4/20 0.48
SMN1; SMN2 Q16637 4/20 0.48
RAB9A P51151 4/20 0.46
LMNA P02545 2/20 0.46
HSD17B10 Q99714 2/20 0.46
NPC1 O15118 2/20 0.46
TP53 P04637 1/20 0.46
GAA P10253 1/20 0.46
MAPT P10636 1/20 0.46
PKM P14618 1/20 0.46
RPA1 P27694 1/20 0.43
MAPK10 P53779 1/20 0.43
DAO P14920 1/20 0.42
ADORA3 P0DMS8 1/20 0.42
ADORA1 P30542 2/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
ADORA2A P29274 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23504053 0.82 KDM4E (0.47) ALDH1A1KDM4EHPGDSMN1; SMN2RAB9A
SCHEMBL23504050 0.81 KDM4E (0.46) ALDH1A1KDM4EHPGDSMN1; SMN2RAB9A
SCHEMBL20929343 0.80 KDM4E (0.57) ALDH1A1KDM4EHPGDSMN1; SMN2RAB9A
SCHEMBL21101501 0.78 KDM4E (0.46) ALDH1A1KDM4EHPGDSMN1; SMN2RAB9A
SCHEMBL22472375 0.77 KDM4E (0.38) ALDH1A1KDM4EHPGDSMN1; SMN2RAB9A
SCHEMBL1698065 0.75 KDM4E (0.53) ALDH1A1KDM4EHPGDSMN1; SMN2RAB9A
SCHEMBL17570840 0.75 KDM4E (0.49) ALDH1A1KDM4EHPGDSMN1; SMN2RAB9A
SCHEMBL17570857 0.74 KDM4E (0.46) ALDH1A1KDM4EHPGDSMN1; SMN2RAB9A
SCHEMBL17570856 0.74 KDM4E (0.46) ALDH1A1KDM4EHPGDSMN1; SMN2RAB9A
SCHEMBL17142361 0.72 KDM4E (0.47) ALDH1A1KDM4EHPGDSMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230192738-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-06-22 US disclosed
US-11038137-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2021-06-15 US disclosed
EP-2993215-B1 Azabenzimidazo[2,1-a]benzimidazoles for electronic applications IDEMITSU KOSAN CO (JP) 2019-06-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192738-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OPRM1, OPRD1, OXER1 ALDH1A1 683/4885KDM4E 3356/4885HPGD 2544/4885
US-11038137-B2 Organic electroluminescent materials and devices ORC3, NUDC, AOC1 ALDH1A1 2725/4885KDM4E 2173/4885HPGD 1230/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.